Wednesday, September 17, 2008
FDA Blocks Imports of Generic Drugs from India
With Wall Street’s hot economic meltdown clouding up the financial landscape like a five alarm fire at a bacon filled smokehouse, you’d think this election cycle would be the perfect time for the Democrats to open up a dialogue about what this sorry ass of a country can start making around here again. How about drugs?
The FDA announced today that the U.S. government is blocking imports of thirty drugs by an Indian drug manufacturer at two of its sites for “failure to correct significant problems” that could pose potential health threats to American residents.
India’s “giant” drug manufacturer Ranxbary Laboratories has failed to correct “significant manufacturing problems that could lead to allergic reactions or other problems.” No mention was made of which specific drugs were being blocked or what kind of “other problems” loom at large. The FDA is, however, allowing India’s Ranxbary Laboratories to “continue selling medicines made at any of its other factories.”
Of particular note is that upon doing a Google search for the "giant" “Ranxbary Laboratories” to learn more about its facilities and other factory locations, no website exists for them and only a total of three vague links to their name displayed with references to other Ranxbary drug recalls, such as Fentanyl drug patches.
Good for the FDA for taking these measures. Although this article doesn't tell us much, it does pose a few boring questions such as: How many more drug manufacturers are in a similar position? And why are so many American pharmaceutical companies laying off people here? What happens to them? Maybe it's time for a beefed up FDA payroll budget and they can pick them up. At the very least, it would be as a good place to start.